lntesta Pylostat ^® is food for special medical purposes in the form of sachets for dietary management during and after Helicobacter Pylori eradication therapy . This therapy involves the use of antibiotics and drugs that reduce the secretion of gastric acid in order to eliminate the H. pylori bacteria, responsible for stomach diseases such as chronic inflammation of the mucous membrane. Thanks to the synergy of the ingredients, lntesta Pylostat ^® promotes better treatment tolerance, supports the regeneration of the digestive system and helps to regain digestive comfort faster after the end of therapy.

What does Intesta Pylostat ^® contain?

lntesta Pylostat ^® sachets contain three key ingredients:

• Microencapsulated sodium butyrate MSB ^® – a patented form that gradually releases the substance along the entire length of the intestine. Butyrate plays an important role in nourishing intestinal cells, supporting their proper structure and functioning, which may reduce the risk of side effects of antibiotic therapy.
• Probiotic S. boulardii CNCM I-3799 - a non-pathogenic yeast strain that helps reduce side effects associated with antibiotic therapy. Its effectiveness and safety, especially during and after Helicobacter pylori eradication, have been confirmed in clinical trials.
• Postbiotic L. reuteri DSM 17648 - inactivated bacteria with proven effectiveness in clinical trials.

The appropriate composition of Intesta Pylostat ^® ingredients supports the body during therapy and during the convalescence period, helping to restore balance in the digestive tract.